Weck

McCune Law Group Obtains Landmark $10 Million Settlement on Behalf of Military Veteran and Police Officer Against San Bernardino County

Retrieved on: 
Thursday, February 22, 2024
MLG, SAN, Injury, Safety, Comment, Weck, SUV, Life, Assumption of risk, Tetraplegia

SAN BERNARDINO, Calif., Feb. 22, 2024 /PRNewswire/ -- Personal Injury attorneys Cory Weck and Brynna Popka of McCune Law Group (MLG) have successfully secured a settlement for military veteran and police officer Jay Youngblood in a major litigation against San Bernardino County for life-changing injuries Youngblood sustained while undergoing the County's traffic officer motorcycle training.

Key Points: 
  • SAN BERNARDINO, Calif., Feb. 22, 2024 /PRNewswire/ -- Personal Injury attorneys Cory Weck and Brynna Popka of McCune Law Group (MLG) have successfully secured a settlement for military veteran and police officer Jay Youngblood in a major litigation against San Bernardino County for life-changing injuries Youngblood sustained while undergoing the County's traffic officer motorcycle training.
  • Popka and Weck sought to resolve this matter quickly for Youngblood, stating "he [Youngblood] is so deserving of this positive outcome."
  • MLG is proud to report this litigation has affected change for the better for motorcycle officers in San Bernardino County.
  • Since the settlement of this matter, the County has shut down its training course.

McCune Law Group Partner Cory Weck Awarded Jennifer Brooks Lawyer of the Year by Western San Bernardino County Bar Association

Retrieved on: 
Monday, October 9, 2023
Naval War College, Officer, Department of Defense police, United States Marine Corps Judge Advocate Division, Ethics, MLG, University, Weck, Cornell University, Air force, Child, Marines, Personal injury, Comment, Nursing, Inland Empire

ONTARIO, Calif., Oct. 9, 2023 /PRNewswire/ -- On October 5, 2023, the Western San Bernardino County Bar Association hosted their annual 2023-2024 Installation of Officers and Awards Ceremony in Ontario, California. Alongside Scaffidi Law, McCune Law Group was honored to sponsor the event, but it is also home to the recipient of the WSBCSA's Jennifer Brooks Lawyer of the Year award – MLG Partner Cory Weck.

Key Points: 
  • ONTARIO, Calif., Oct. 9, 2023 /PRNewswire/ -- On October 5, 2023, the Western San Bernardino County Bar Association hosted their annual 2023-2024 Installation of Officers and Awards Ceremony in Ontario, California.
  • Alongside Scaffidi Law, McCune Law Group was honored to sponsor the event, but it is also home to the recipient of the WSBCSA's Jennifer Brooks Lawyer of the Year award – MLG Partner Cory Weck.
  • For decades, Weck has served the Inland Empire community and the country through his legal and military service.
  • To arrange comment on this award from Cory Weck, please contact MLG's Public Relations department at [email protected] .

Teleflex Earns Top Spot in MedReps Best Places to Work 2023 Ranking

Retrieved on: 
Monday, November 21, 2022
Urology, Culture, Teleflex, Organization, Corporation, Patient, Radiology, TFX, Annual report, Anesthesia, Weck, Core values, Security (finance), Prostatic urethral lift, NYSE, Health, Emergency medicine, LMA, Management, Risk management, QuikClot

Its great to be named a Best Place to Work for the sixth consecutive year, said Liam Kelly, Chairman, President, and CEO at Teleflex.

Key Points: 
  • Its great to be named a Best Place to Work for the sixth consecutive year, said Liam Kelly, Chairman, President, and CEO at Teleflex.
  • Teleflex employees are committed to living our Core Values and putting people at the center of everything we do.
  • Employees have a choice on where they work, and we are proud that they choose to work with Teleflex.
  • To learn more about the MedReps Best Places to Work 2023 Report, click here.

Teleflex Announces Worldwide Recall of Gibeck® Iso-Gard® Filter

Retrieved on: 
Thursday, November 3, 2022
Online, Fax, Food, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Letter, Probability, FDA, Prostatic urethral lift, Anesthesia, Urology, Weck, Radiology, Annual report, ET, U.S. Securities and Exchange Commission, Injury, LMA, Desaturation, Quarantine, Health, Filter, Security (finance), Emergency medicine, Patient, Solution, Medical device, Teleflex, QuikClot

Teleflex initiated this voluntary recall on August 29, 2022 due to reports received indicating that the device split or detached during use.

Key Points: 
  • Teleflex initiated this voluntary recall on August 29, 2022 due to reports received indicating that the device split or detached during use.
  • Teleflex is currently issuing an expansion to this recall to include additional lots.
  • Teleflex requests that users immediately check their inventory for product within the scope of this recall.
  • On October 14, 2022, the U.S. Food and Drug Administration (FDA) classified the recall of Gibeck Iso-Gard Filters as a Class I recall.

Teleflex Completes Acquisition of Standard Bariatrics

Retrieved on: 
Wednesday, September 28, 2022
Weck, Health, NYSE, Legislation, Anesthesia, Company, Acquisition, LMA, Achievement, U.S. Securities and Exchange Commission, Patient, Emergency medicine, Medicaid, Solution, Annual report, Teleflex, EPS, Bariatric surgery, Stock dilution, Security (finance), GLOBE, Prostatic urethral lift, Urology, Bariatrics, TFX, Radiology, Health insurance, Medicare, QuikClot

WAYNE, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of Standard Bariatrics, Inc., which has commercialized an innovative powered stapling technology for bariatric surgery.

Key Points: 
  • WAYNE, Pa., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has completed the previously announced acquisition of Standard Bariatrics, Inc., which has commercialized an innovative powered stapling technology for bariatric surgery.
  • On August 22, Teleflex announced its entry into a definitive agreement to acquire Standard Bariatrics.
  • Under the terms of the agreement, Teleflex acquired Standard Bariatrics for $170 million at closing, with additional consideration of up to $130 million payable upon the achievement of certain commercial milestones.
  • Teleflex, the Teleflex logo, Arrow, Deknatel, LMA, Pilling, QuikClot, Rsch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio

Retrieved on: 
Tuesday, September 27, 2022
Weck, Workflow, Health, Contraindication, PICC, NYSE, Thrombosis, Anesthesia, Pressure, LMA, U.S. Securities and Exchange Commission, Patient, Emergency medicine, Mean line, Solution, Annual report, General manager, Teleflex, Research, Security (finance), GLOBE, Prostatic urethral lift, Arrow, Urology, TFX, Radiology, Tegaderm, Medical device, Pharmaceutical industry, Medical imaging, Frederick B. Deknatel, QuikClot

WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) releases their new Arrow Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion.

Key Points: 
  • WAYNE, Pa., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) releases their new Arrow Pressure Injectable Midline portfolio in the US and Canada, designed to help alleviate line identification confusion.
  • Teleflex conducted extensive research with industry-leading vascular access professionals to select the enhancements in the new Arrow Midline Catheters.
  • Teleflex is the home of Arrow, Deknatel, LMA, Pilling, QuikClot, Rsch, UroLift, and Weck trusted brands united by a common sense of purpose.
  • Teleflex, the Teleflex logo, Arrow, Arrowg+ard Blue Advance, Deknatel, LMA, Pilling, QuikClot, Rusch, UroLift, and Weck are trademarks or registered trademarks of Teleflex Incorporated or its affiliates, in the U.S. and/or other countries.

Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference

Retrieved on: 
Thursday, September 15, 2022
Weck, Health, MANTA, Karolinska Institute, NYSE, Canadian International Council, SAFE, Anesthesia, VCDS, CRF, Percutaneous, Device, LMA, Interventional cardiology, TAVI, U.S. Securities and Exchange Commission, Patient, Emergency medicine, Karolinska University Hospital, Solution, Annual report, Clinical trial, Teleflex, VCD, International Journal of Cardiology, Security (finance), 1048, Observational study, GLOBE, Prostatic urethral lift, Urology, Catheter, Veni, vidi, vici, TFX, TCT, Radiology, MARVEL, Medical device, Medical imaging, Cardiology, Pilling, QuikClot

TCT is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the world's foremost educational forum specializing in interventional cardiovascular medicine.

Key Points: 
  • TCT is the Cardiovascular Research Foundation's (CRF) annual scientific symposium and the world's foremost educational forum specializing in interventional cardiovascular medicine.
  • The findings of our study indicate that the MANTA Device is easy to learn and has a short learning curve, which is in line with our user experience.
  • The MANTA Device is the first commercially available biomechanical vascular closure device designed specifically for large bore femoral arterial access site closure.
  • Percutaneous plug-based vascular closure device in 1000 consecutive transfemoral transcatheter aortic valve implantations.

Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery

Retrieved on: 
Monday, August 22, 2022
Patient safety, P, Security (finance), Medicaid, Bariatrics, Technology, NYSE, Legislation, Emergency medicine, Metabolism, Acquisition, Bariatric surgery, Achievement, Solution, Urology, American Society for Metabolic & Bariatric Surgery, Society, Teleflex, TFX, Radiology, Estimation, American College, U.S. Securities and Exchange Commission, Surgical Endoscopy, Fellowship of the Royal Colleges of Surgeons, Anatomy, GLOBE, Surgeon, Thompson, Company, Anesthesia, LMA, Association, Natural borrowing limit, Prostatic urethral lift, Annual report, Martin J. Goodman, Weck, EPS, Patient, Health, Health insurance, Pharmaceutical industry, Bank, Video game, Mittal, QuikClot, Medicare, Titan

Additionally, the design may result in a more secure staple line and fewer chances of leaks, as evidenced with higher burst pressures4.

Key Points: 
  • Additionally, the design may result in a more secure staple line and fewer chances of leaks, as evidenced with higher burst pressures4.
  • In addition, the deal enables Teleflex to leverage our strength in our existing bariatric surgeon call point, with a differentiated product that complements many of our key surgical products, including our ligation portfolio, MiniLap Percutaneous Surgical System and Weck EFx Fascial Closure Portfolio.
  • Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care.
  • American Society for Metabolic and Bariatric Surgery, Estimate of Bariatric Surgery Numbers, 2011-2020, published June 2022.

Teleflex awarded Central Venous Access contract from Vizient

Retrieved on: 
Monday, August 1, 2022
Blood vessel, Urology, Silver sulfadiazine, American Journal of Infection Control, Security (finance), NP, ME, Infection Control & Hospital Epidemiology, Central venous catheter, Infection, American Journal, U.S. Securities and Exchange Commission, Tracheotomy, Fungus, CLABSI, Solution, CVC, TFX, Teleflex, Radiology, Chlorhexidine, Central, GLOBE, Health, General manager, Thrombosis, Comparison, GA, Hypersensitivity, Annual report, Daniele Buetti, Anesthesia, Weck, LMA, Bloodstream infections, Centers for Disease Control and Prevention, NYSE, Risk, YZ, Burns, Gram-negative bacteria, Patient, CFR, Prostatic urethral lift, Center, Emergency medicine, Medical device, Medical imaging, Health insurance, Birth control, Wood drying, Pharmaceutical industry, Arrow, QuikClot, Vizient, Inc., Frederick B. Deknatel

WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access products from Vizient, Inc., the nations largest member-driven healthcare performance improvement company.

Key Points: 
  • WAYNE, Pa., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has been awarded a contract for the supply of Central Venous Access products from Vizient, Inc., the nations largest member-driven healthcare performance improvement company.
  • This new agreement allows Vizient members to take advantage of special pricing and terms pre-negotiated by Vizient for Central Venous Access products.
  • As the market leader in Central Venous Catheters (CVCs)1, we are pleased to offer Vizient members one of the broadest portfolios of central access products available, said Lisa Kudlacz, President and General Manager, Teleflex Vascular.
  • The group purchasing agreement includes access to Teleflex Arrowg+ard Blue Plus CVCs and Arrow ErgoPack Complete Systems.

Teleflex Publishes 2021 Global Impact Report

Retrieved on: 
Friday, July 29, 2022
People, Anesthesia, Urology, Carbon footprint, Corporation, GLOBE, Weck, LMA, Lead, U.S. Securities and Exchange Commission, Global, Environment, Corporate social responsibility, GRI, Disclosure, Emergency medicine, NYSE, Culture, Electricity, Solution, Health, Safety, Sustainability Accounting Standards Board, Work, Security (finance), Patient, Prostatic urethral lift, TFX, Environmental health, Annual report, Sustainability accounting, Program, Radiology, CSR, DEI, Prosperity, EHS, Management, Medical imaging, Risk management, QuikClot, Teleflex, Ethics

WAYNE, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has published its 2021 Global Impact Report.

Key Points: 
  • WAYNE, Pa., July 29, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that it has published its 2021 Global Impact Report.
  • The 2021 Global Impact Report outlines accomplishments and plans for each of the companys four CSR pillars: Principles of Ethics & Governance, Planet & Environment, People, and Prosperity & Sustainable Healthcare.
  • Welcomed new Co-Chair Shant Demary to the Global DEI council, implemented global inclusive training for leaders, and continued to support expansion of access to healthcare through the Teleflex Foundation.
  • Teleflex is a global provider of medical technologies designed to improve the health and quality of peoples lives.